FDA Adverse Event Injury Summary report: N

LIGHT ADJUSTABLE LENS (LAL)

MDR report key: 12447781 · Received September 9, 2021

Report

Report Number
3012712027-2021-00051
Event Type
Injury
Date Received
September 9, 2021
Report Date
September 9, 2021
Manufacturer
RXSIGHT, INC.
Product Code
PZK
UDI-DI
00818806020302
PMA / PMN Number
P160055
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
HI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE SITE REPORTED THAT A LIGHT ADJUSTABLE LENS HAD BEEN EXPLANTED FROM THE PATIENT. UPON FOLLOW-UP, THE SITE REPORTED THAT THE LIGHT ADJUSTABLE LENS HAD BEEN EXPOSED TO AMBIENT UV LIGHT PRIOR TO LOCK IN. RXSIGHT'S FIRST AWARENESS OF THIS WAS 8/17/2021. THE EXPLANTED LENS WAS RETURNED FOR EVALUATION. THE LENS WAS CUT INTO MULTIPLE FRAGMENTS. VISUAL INSPECTION AND OPTICAL TESTING OF THE LENS CONFIRMED THE PRESENCE OF AN AMBIENT ZONE, WHICH IS INDICATIVE OF AMBIENT UV LIGHT EXPOSURE PRIOR TO LOCK IN.

Description of Event or Problem · 0

THE SITE REPORTED THAT A LIGHT ADJUSTABLE LENS HAD BEEN EXPLANTED FROM THE PATIENT. UPON FOLLOW-UP, THE SITE REPORTED THAT THE LIGHT ADJUSTABLE LENS HAD BEEN EXPOSED TO AMBIENT UV LIGHT PRIOR TO LOCK IN. RXSIGHT'S FIRST AWARENESS OF THIS WAS 8/17/2021.

Additional Manufacturer Narrative · 1

THE SITE REPORTED THAT A LIGHT ADJUSTABLE LENS HAD BEEN EXPLANTED FROM THE PATIENT. NO ADDITIONAL INFORMATION HAS BEEN PROVIDED AT THIS TIME. RXSIGHT'S FIRST AWARENESS OF THIS WAS 8/17/2021. THE DEVICE HISTORY RECORD FOR THE LENS WAS REVIEWED. NO ISSUES WERE NOTED. THE LENS IS CURRENTLY BEING EVALUATED.

Description of Event or Problem · 1

THE SITE REPORTED THAT A LIGHT ADJUSTABLE LENS HAD BEEN EXPLANTED FROM THE PATIENT. NO ADDITIONAL INFORMATION HAS BEEN PROVIDED AT THIS TIME. RXSIGHT'S FIRST AWARENESS OF THIS WAS 8/17/2021.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1343344 LIGHT ADJUSTABLE LENS (LAL) LIGHT ADJUSTABLE LENS (LAL) PZK RXSIGHT, INC. 60005 L02-001507 00818806020302

Patients

Seq Age Sex Outcome Treatment
1 Other